Associations between Use of β Blockers or NSAIDs* and Specific Neurological Deficits after Controlling for Age and BMI in Subjects Who Had no Diseases Known to Cause Peripheral Neuropathy and Who Were Still Enrolled in Year 3 of the Study (N = 287)*
| Predictor Variables | Coefficient | Standard Error | P Value | |
|---|---|---|---|---|
| PN(ankle)† | BETA | 1.24 | 0.43 | 0.004 |
| (N = 50) | NSAID | 0.50 | 0.37 | 0.18 |
| PN(touch) | BETA | 0.23 | 0.80 | 0.77 |
| (N = 16) | NSAID | 1.21 | 0.54 | 0.02 |
| PN(position) | BETA | 1.90 | 0.97 | 0.05 |
| (N = 5) | NSAID | 1.93 | 0.96 | 0.04 |
| PN(vibration) | BETA | 1.44 | 0.95 | 0.13 |
| (N = 7) | NSAID | 3.27 | 1.07 | 0.002 |
* Statistical analysis was done by logistic regression.
† PN(ankle), subjects who had deficit in ankle reflex; PN(touch), subjects who had deficit in touch sensation; PN(position), subjects who had deficit in position sensation; PN(vibration), subjects who had deficit in vibration sensation.